A Whole Cell Pathway Screen Reveals Seven Novel Chemosensitizers to Combat Chloroquine Resistant Malaria

  title={A Whole Cell Pathway Screen Reveals Seven Novel Chemosensitizers to Combat Chloroquine Resistant Malaria},
  author={Jun-Hong Ch'ng and Sachel Mok and Zbynek Bozdech and Martin J. Lear and Aicha Boudhar and Bruce M Russell and François H. Nosten and Kevin Shyong-Wei Tan},
  journal={Scientific Reports},
Due to the widespread prevalence of resistant parasites, chloroquine (CQ) was removed from front-line antimalarial chemotherapy in the 1990s despite its initial promise of disease eradication. Since then, resistance-conferring mutations have been identified in transporters such as the PfCRT, that allow for the efflux of CQ from its primary site of action, the parasite digestive vacuole. Chemosensitizing/chemoreversing compounds interfere with the function of these transporters thereby… 

Overcoming Chloroquine Resistance in Malaria: Design, Synthesis, and Structure-Activity Relationships of Novel Hybrid Compounds

Assessment of aqueous solubility, membrane permeability, and in vitro toxicity in a hepatocyte line and a cardiomyocyte line indicates that compound 35 has a good therapeutic window and favorable drug-like properties.

Characterization of the Commercially-Available Fluorescent Chloroquine-BODIPY Conjugate, LynxTag-CQGREEN, as a Marker for Chloroquine Resistance and Uptake in a 96-Well Plate Assay

A commercially-available green fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, is reported here as a proxy forchloroquine accumulation, and inhibited growth of chloroquin-sensitive strain 3D7 more extensively than in the resistant strains 7G8 and K1.

A High-Content Phenotypic Screen Reveals the Disruptive Potency of Quinacrine and 3′,4′-Dichlorobenzamil on the Digestive Vacuole of Plasmodium falciparum

A high-content screening method to select compounds that can disrupt the parasite vacuole, as measured by the leakage of intravacuolar Ca2+ is developed, with the potential to provide mechanistic insights to the activity of antimalarial drugs.

A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.

The synthesis and characterization of a pH-sensitive fluorescent chloroquine analogue consisting of 7-chloro-N-{2-[(propan-2-yl)amino]ethyl}quinolin-4-amine functionalized with the fluorochrome 7-nitrobenzofurazan (NBD) is reported, termed Fluo-CQ.

Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis.

This study led to the identification of novel compounds, termed hybrid efflux pump inhibitors, with intrinsic antimycobacterial activities and intracellular activity in macrophages at a low concentration.

Current scenario and future strategies to fight artemisinin resistance

The current proposed mechanisms of ART activity, resistance strategies adopted by the parasite in response to ACTs and possible future approaches to mitigate the spread of resistance from South-East Asia are covered.

Role of Plasmodium falciparum transporters in drug resistance

Results point to the fact that the parasite susceptibility towards CQ and QN is regulated by phosphorylation, although the exact molecular mechanism needs to be further examined.

Phenotypic characterization of chloroquine resistance in Plasmodium spp. isolates

This thesis contributed to the improvement of ex vivo tools for drug resistance surveillance and the screening of novel anti-malarial lead compounds and provided a prerequisite for more in-depth genomic studies on the molecular determinants of anti- malarial resistance.

Targeting Artemisinin-Resistant Malaria by Repurposing the Anti-Hepatitis C Virus Drug Alisporivir

The rational repurposing of the anti-hepatitis C virus drug, alisporivir, a nonimmunosuppressive analog of cyclosporin A, against artemisinin-resistant strains of P. falciparum supports the hypothesis that targeting resistance mechanisms is a viable approach toward dealing with drug-resistant parasite.



Spiroindolones, a Potent Compound Class for the Treatment of Malaria

The preclinical profile for an optimized spiroindolone drug candidate, NITD609, shows pharmacokinetic properties compatible with once-daily oral dosing and has single-dose efficacy in a rodent malaria model.

Inhibition of efflux of quinolines as new therapeutic strategy in malaria.

The main elements of quinoline resistance and reversion of qu inoline resistance related to malaria are summarized.

Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.

  • D. V. van SchalkwykT. Egan
  • Medicine, Biology
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • 2006

Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets

Using high-throughput chemical screening and genome-wide association analysis, 32 highly active compounds and genetic loci associated with differential chemical phenotypes (DCPs) are identified, defined as greater than or equal to fivefold differences in half-maximum inhibitor concentration (IC50) between parasite lines.

Strategies to reverse drug resistance in malaria

The main focus is recent reports on chloroquine resistance-reversing agents, including primaquine, so-called ‘reversed chloroquines’, novel resistance reversers such as xanthenes and two new mefloquine Resistance reversers, most notably HIV protease inhibitors.

In Vivo and In Vitro Antimalarial Properties of Azithromycin-Chloroquine Combinations That Include the Resistance Reversal Agent Amlodipine

These data discount amlodipine as an additional partner for chloroquine-based combination therapy, but continue to support azithromycin as a safe and effective addition to antimalarial combination therapies.

Drug-induced permeabilization of parasite's digestive vacuole is a key trigger of programmed cell death in Plasmodium falciparum

It was demonstrated for the first time that micromolar concentrations of CQ partially permeabilized the parasite's digestive vacuole (DV) membrane and that this important upstream event appears to precede mitochondrial dysfunction.

Quantitative genome re-sequencing defines multiple mutations conferring chloroquine resistance in rodent malaria

Quantitative trait loci conferring selectable phenotypes, such as drug resistance, can be mapped directly using progressive genome-wide linkage group selection and generate insights regarding the genetic architecture and mechanisms of resistance to chloroquine and other drugs.